Fresh off global validation of their Covid-19 vaccine’s extraordinary effectiveness, Russian developers are in talks with China’s CanSino Biologics Inc. to test a combined regimen of their shots to better protect against new virus strains, according to people with knowledge of the matter.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591, and plans to focus its SARS-CoV-2/COVID-19 research strategy and production capabilities on advancing two therapeutic candidates, MK-4482 and MK-7110.
itt Researchers Demonstrate First Successful Use of Biodegradable Magnesium-alloy Stent for Pediatric Patients
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a partnership with the United Kingdom’s (UK) National Health Service (NHS) to help transform cancer outcomes by making GRAIL’s multi-cancer early detection blood test, Galleri™, available to UK patients starting in 2021.
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results. The Lucira COVID-19 All-In-One Test Kit is a molecular (real-time loop mediated amplification reaction) single use test that is intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19.
Apple's ECG app and irregular heart rhythm notifications on the Apple Watch Series 4 and 5 have received domestic approval and certification from Japan's medical authorities, indicating that both features should go live in the country very soon.
Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc (PFE.N) and BioNTech (22UAy.F), and French group Valneva (VLS.PA), the business ministry said on Monday.